This finding supports the peptides suitability for extended treatment protocols when clinically appropriate
Lotte Bjerre Knudsen (43:30): I think we've been around all the exciting biology of GLP-1, both in diabetes, obesity, cardiovascular, kidney, potential in Alzheimer's and addiction
Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients
During a video consultation, your MDWatch provider reviews your medical history, current medications, and goals to determine whether GLP1 is appropriate
This gap is particularly relevant given the common use of systemic immunomodulators in dermatology patients, creating challenges for clinicians considering GLP-1 RAs in polypharmacy contexts
I think it can be appropriate as an interim solution while were aggressively working on lifestyle changes to both mitigate side effects and keep them in a healthy place. Dr